semaglutide and thyroid tumors New Research Challenges Fears of Semaglutide-Linked Cancer Risk Ozempic Thyroid Cancer Lawsuit

Its a mountain of paperwork, but it unlocks all your future clinical revenue

August 2025 : The US FDA approved Wegovy (semaglutide 2.4 mg) for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), in combination with a reduced-calorie diet and increased physical activity

Am J Surg Pathol (2001) 25(2):20511

Methylcobalamin in lipo C formulations maintains adequate B12 status during active weight loss, but once injections are discontinued, oral supplementation (1000mcg daily sublingual methylcobalamin) should continue for 812 weeks to prevent rebound deficiency

Avoiding carbonated beverages, caffeine, and alcohol can reduce gastric irritation